Showing results 5 to 7 of 7
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2019 | ||||
SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists Journal:Emerging Microbes & Infections | 2020 | 83 | ||
Suppression of SARS‐CoV‐2 infection in ex‐vivo human lung tissues by targeting class III phosphoinositide 3‐kinase Journal:Journal of Medical Virology | 2021 | 4 |